Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

GSK team identifies new 5-HT5A receptor ligands for CNS disorders

Jan. 13, 2005

Researchers at Actelion disclose orexin receptor antagonists

Jan. 13, 2005

New agents for Alzheimer's disease claimed by De Novo

Jan. 13, 2005

Unique dual-binding AChE inhibitor with potent Abeta antiaggregating activity

Jan. 13, 2005

Phase III study planned for Mylinax in MS

Jan. 13, 2005

Muscarinic M1 receptor antagonists emerge from research at Lilly

Jan. 12, 2005

Valeant submits complete response for Zelapar

Jan. 12, 2005

Elan/Pfizer collaboration produces novel BACE inhibitors

Jan. 11, 2005

CRF-1 receptor antagonists in early development at Pfizer

Jan. 11, 2005

Rotigotine patch effective in moderate to severe restless legs syndrome

Jan. 11, 2005

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026